Latest Releases
U.S. Senator Tina Smith’s Statement on the BNSF Train Derailment
WASHINGTON, D.C. [03/30/23] — Today, U.S. Senator Tina Smith (D-Minn.) issued the following statement in response to this morning’s BNSF train derailment in Raymond, Minnesota, and also announced she’s cosponsoring the legislation to improve railway safety standards: “Thanks to the incredible first responders in Raymond and Kandiyohi County, Minnesota, this morning’s train derailment appears to be contained. I’m grateful for their quick response and leadership that kept Minnesotans safe. But today’s derailment is another reminder that Congress needs to act on rail safety now. I’m cosponsoring the bipartisan Railway Safety Act to enact commonsense rail safety measures and help prevent future disasters.” The bipartisan Railway Safety Act was introduced earlier this month by Sen. Sherrod Brown (D-Ohio) and Senator JD Vance (R-Ohio) and is designed to improve safety requirements for trains transporting dangerous or hazardous material and help communities affected by derailments. The bill is also cosponsored by Senators Amy Klobuchar (D-Minn.), Bob Casey (D-Pa.), John Fetterman (D-Pa.), Marco Rubio (R-Fla.), and Josh Hawley (R-Mo.).
U.S. Senators Smith, Braun Reintroduce Bipartisan Legislation to Address Big Pharma Ploy That Keeps Drug Prices High for Consumers
WASHINGTON – Today, U.S. Senators Tina Smith (D-MN) and Mike Braun (R-IN), reintroduced bipartisan legislation to address a big pharma ploy that prevents access to affordable prescription drugs for millions of people across the country. The Expanding Access to Low-Cost Generics Act—which was the first piece of Senate legislation introduced by Sen. Smith in 2018—addresses an anti-competitive prescription drug practice called “parking.” “Parking” occurs when a brand name manufacturer agrees not to sue the first company that submits an application to create a generic version of that drug—a so-called “first filer”—as long as the generic company agrees to delay bringing that generic drug to market. No other company can bring a generic version of a brand name drug to market until 180 days after the first filer has done so. These anti-competitive agreements among drug companies allow fewer lower-cost generic products to come to market and keep prices higher for consumers. Right now at least 75 percent of “first filer” generic products have delayed their market entry due to “parking” arrangements with brand-name companies. The Senators’ bipartisan bill takes major steps toward eliminating this practice. “When I travel around Minnesota, the high price of prescription drugs is always one of the first things families and seniors talk to me about,” said Sen. Smith, a member of the Senate Health Committee. “This bill takes important steps toward ending anti-competitive practices that big pharmaceutical companies exploit to keep drug prices high and unaffordable for people in Minnesota and across the country.” “Everywhere
U.S. Senators Smith & Klobuchar Announce Public Housing Fire Safety Act Following Tragic Fire in Minneapolis
WASHINGTON, D.C. [12/18/2019]—Today, U.S. Senators Tina Smith and Amy Klobuchar (D-Minn.) introduced legislation—the Public Housing Fire Safety Act—that would create a program to provide support to public housing authorities who wish to retrofit older high-rise apartment buildings with sprinkler systems. The Federal Fire Safety Act of 1992 required the installation of sprinklers in all new government-owned high rise buildings. However, there are thousands of public housing apartment buildings around the country built before that date. According to data from the Department of Housing and Urban Development (HUD), for example, nearly all of the high-rise public housing buildings in Minneapolis, Minnesota were
As 2020 Budget Agreement is Passed, Key Bipartisan Measures U.S. Senator Tina Smith Authored & Championed Set to Become Law and Benefit Minnesotans
WASHINGTON, D.C. [12/18/19]—As Congress sends its final budget agreement for 2020 to the President’s desk, Minnesotans will benefit from several bipartisan measures U.S. Senator Tina Smith (D-Minn.) authored and championed. Sen. Smith’s bipartisan efforts to address health care costs and skyrocketing prescription drug prices, support rural housing, ramp up clean energy, expand disaster relief to hard-hit farmers and preserve electric cooperatives’ tax-exempt status while expanding much-needed broadband services in rural communities were all included in the final budget package expected to be signed into law in the coming days. “Here we are at the end of the year, and
U.S. Senators Tina Smith, Mike Braun Introduce Bipartisan Bill to Address Underhanded Big Pharma Tactic That Prevents Americans from Accessing Affordable Rx Drugs
WASHINGTON, D.C. [12/18/19]—Today, U.S. Senators Tina Smith (D-Minn.) and Mike Braun (R-Ind.) introduced legislation to bring low-cost generics to market, increase competition and help American families and seniors access their medications. The Expanding Access to Low-Cost Generics Act—which was the first standalone piece of legislation introduced by Sen. Smith—gets to the heart of a major concern families are facing right now: prescription drug prices. Nearly three in ten Americans report that they did not fill a prescription because it was too expensive. Anti-competitive behavior between brand name and generic drug manufacturers is delaying timely access to low-cost generic drugs. For example,
U.S. Senators Smith & Collins’ Bipartisan Bill to Combat Lyme and Other Tick-Borne Diseases Advances
WASHINGTON, D.C. [12/17/19]—U.S. Senators Tina Smith (D-Minn.) and Susan Collins (R-Maine) announced that their bipartisan bill to improve research, prevention, diagnostics, and treatment for tick-borne diseases was included in the government spending agreement released yesterday. Once passed by both the House and Senate, the bill will proceed to the President’s desk to be signed into law. The Kay Hagan Tick Act unites the effort to confront the alarming public health threat posed by Lyme disease and other tick-borne diseases, which have risen exponentially from approximately 30,000 cases in 2003 to an estimated 450,000 last year. Sens. Smith and Collins renamed the
English